Rieux-Laucat Frédéric
Unité INSERM 429, Université Paris V, Hopital Necker Enfants Malades, Paris, France.
Curr Dir Autoimmun. 2006;9:18-36. doi: 10.1159/000090769.
The death receptor Fas/TNFRSF6 is a key player in lymphocyte apoptosis induction. Patients lacking a functional Fas/TNFRSF6 receptor develop a chronic lymphoproliferation termed Autoimmune LymphoProliferative Syndrome (ALPS), characterized by a benign tumoral syndrome, autoimmune cytopenias, hyperglobulinemia (G and A) and accumulation of TCRalphaBeta CD4-CD8- cells (called double-negative, or DN, T cells). Inherited mutations in the TNFRSF6 gene are responsible for most ALPS cases (ALPS-I). Caspase 10 gene mutations are found in a few of the remaining cases (ALPS-II). In a third group of patients (ALPS-III), somatic mosaicism of Fas/TNFRSF6 mutations as found in sporadic cases. Consequences of this finding will be discussed in terms of functional and molecular diagnosis as well as in the understanding of the pathophysiological basis of ALPS.
死亡受体Fas/TNFRSF6是诱导淋巴细胞凋亡的关键因子。缺乏功能性Fas/TNFRSF6受体的患者会发生一种称为自身免疫性淋巴细胞增殖综合征(ALPS)的慢性淋巴细胞增殖,其特征为良性肿瘤综合征、自身免疫性血细胞减少、高球蛋白血症(G和A)以及TCRαβ CD4-CD8-细胞(称为双阴性或DN T细胞)的积累。TNFRSF6基因的遗传突变是大多数ALPS病例(ALPS-I)的病因。在其余少数病例(ALPS-II)中发现了半胱天冬酶10基因突变。在第三组患者(ALPS-III)中,散发病例存在Fas/TNFRSF6突变的体细胞镶嵌现象。将从功能和分子诊断以及对ALPS病理生理基础的理解方面讨论这一发现的后果。